Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia-MedSci.cn

Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia

Saygin, C; Grieselhuber, N; Blachly, J; Byrd, JC; Vasu, S; Larkin, K; Behbehani, G; Long, MX; Walker, A; Bhatnagar, B; Mims, A

Saygin, C (corresponding author), Ohio State Univ, James Comprehens Canc Ctr, Starling Loving Hall,B301A,320 West 10th Ave, Columbus, OH 43210 USA.; Mims, A (corresponding author), Ohio State Univ, 395 W 12th Ave, Columbus, OH 43210 USA.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia

科室

工具

服务